P/E ratio for Cross Country Healthcare (CCRN)
P/E ratio as of April 2024 (TTM): 6.01
According to Cross Country Healthcare's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 6.01053. At the end of 2022 the company had a P/E ratio of 5.23.
P/E ratio history for Cross Country Healthcare from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 5.23 | -32.36% |
| 2021 | 7.73 | -131.38% |
| 2020 | -24.6 | 241.38% |
| 2019 | -7.22 | -53.72% |
| 2018 | -15.6 | -228.33% |
| 2017 | 12.2 | -79.76% |
| 2016 | 60.0 | -48.72% |
| 2015 | 117 | -1056.83% |
| 2014 | -12.2 | 36.08% |
| 2013 | -8.99 | 156.62% |
| 2012 | -3.50 | -108.84% |
| 2011 | 39.6 | -137.44% |
| 2010 | -106 | -335.04% |
| 2009 | 45.0 | -2477.83% |
| 2008 | -1.89 | -110.24% |
| 2007 | 18.5 | -55.93% |
| 2006 | 42.0 | 5.9% |
| 2005 | 39.6 | 42.45% |
| 2004 | 27.8 | 48.55% |
| 2003 | 18.7 | 23.49% |
| 2002 | 15.2 | -79.4% |
| 2001 | 73.6 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Barrett Business Services BBSI | 17.3 | 187.22% | 🇺🇸 USA |
 ManpowerGroup MAN | 16.8 | 179.93% | 🇺🇸 USA |
 Heidrick & Struggles
HSII | 10.6 | 76.15% | 🇺🇸 USA |
 ASGN ASGN | 20.9 | 247.10% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.